Plasma adiponectin as a predictive factor of survival after a bypass operation for peripheral arterial disease

Journal of Vascular Surgery

Volumn 50, Issue 1, 2009, Pages 95-99

  Komai, Hiroyoshi ^a   Shibata, Rei ^b   Juri, Masanobu ^a   Matsushita, Kunihiro ^b   Ouchi, Noriyuki ^c   Murohara, Toyoaki ^b  

^a Saiseikai Wakayama Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; AORTOFEMORAL BYPASS; ARTERIOGRAPHY; ARTERY BYPASS; ARTERY DISEASE; ARTERY GRAFT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMOROFEMORAL BYPASS; FEMOROPOPLITEAL BYPASS; FEMOROTIBIAL BYPASS; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MALE; PREDICTION; PRIORITY JOURNAL; SURGICAL PATIENT; SURVIVAL; SYMPTOM; SYSTOLIC BLOOD PRESSURE; VEIN GRAFT;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS;

EID: 65649083124     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.12.044     Document Type: Article

References (22)

1. Golledge J., Leicht A., Crowther R.G., Clancy P., Spinks W.L., and Quigley F. Association of obesity and metabolic syndrome with the severity and outcome of intermittent claudication. J Vasc Surg 45 (2007) 40-46
2. Scherer P.E., Williams S., Fogliano M., Baldini G., and Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
3. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
4. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 68 (2004) 975-981
5. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
6. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
7. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
8. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43 (2004) 1318-1323
9. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., and Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36 (2005) 1915-1919
10. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
11. Iwashima Y., Horio T., Suzuki Y., Kihara S., Rakugi H., Kangawa K., et al. Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 188 (2006) 384-390
12. Ouchi N., Ohishi M., Kihara S., Funahashi T., Nakamura T., Nagaretani H., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 (2003) 231-234
13. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
14. Tsutamoto T., Tanaka T., Sakai H., Ishikawa C., Fujii M., Yamamoto T., et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J 28 (2007) 1723-1730
15. George J., Patal S., Wexler D., Sharabi Y., Peleg E., Kamari Y., et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92 (2006) 1420-1424
16. Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Clark L.T., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2 (2006) 2300-2309
17. Al-Omran M., Tu J.V., Johnston K.W., Mamdani M.M., and Kucey D.S. Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study. J Vasc Surg 38 (2003) 279-288
18. Hirose H., Kawai T., Yamamoto Y., Taniyama M., Tomita M., Matsubara K., et al. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes. Metabolism 51 (2002) 314-317
19. Sakamoto K., Sakamoto T., Ogawa H., and Kumamoto Joint Research on Hypercholesterolemia Investigators. The effect of 6 months of treatment with pravastatin on serum adiponectin concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study. Clin Ther 28 (2006) 1012-1021
20. Albers M., Romiti M., Bragança Pereira C.A., Fonseca R.L., and da Silva Júnior M. A meta-analysis of infrainguinal arterial reconstruction in patients with end-stage renal disease. Eur J Vasc Endovasc Surg 22 (2001) 294-300
21. Bosiers M., Deloose K., Verbist J., Schroë H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 43 (2006) 313-318
22. Inoue Y., Sugano N., Jibiki M., Kitamura S., and Iwai T. Cuffed anastomosis for above-knee femoropopliteal bypass with a stretch expanded polytetrafluoroethylene graft. Surg Today 38 (2008) 679-684